CTC
Cetera Trust Company Portfolio holdings
AUM
$167M
This Quarter Return
+2.11%
1 Year Return
+18.74%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$154M
AUM Growth
+$154M
(-5.8%)
Cap. Flow
-$8.41M
Cap. Flow
% of AUM
-5.46%
Top 10 Holdings %
Top 10 Hldgs %
30.32%
Holding
402
New
2
Increased
66
Reduced
103
Closed
15
Top Buys
| 1 |
Sony
SONY
|
$289K |
| 2 |
Baker Hughes
BKR
|
$194K |
| 3 |
American International
AIG
|
$185K |
| 4 |
Chevron
CVX
|
$84.7K |
| 5 |
iShares MSCI EAFE ETF
EFA
|
$81.3K |
Top Sells
| 1 |
Lam Research
LRCX
|
$3.47M |
| 2 |
Blackrock
BLK
|
$2.92M |
| 3 |
CVS Health
CVS
|
$410K |
| 4 |
Dollar General
DG
|
$336K |
| 5 |
Elevance Health
ELV
|
$267K |
Sector Composition
| 1 | Technology | 20.92% |
| 2 | Financials | 17.55% |
| 3 | Healthcare | 15.18% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Discretionary | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Axos Financial
AX
$5.08B
| $358K | 0.23% |
5,130
-135
| -3% | -$9.43K |
|
|
77
Sony
SONY
$162B
| $358K | 0.23% |
16,925
+13,660
| +418% | +$289K |
|
|
78
CVS Health
CVS
$94.2B
| $355K | 0.23% |
7,918
-9,125
| -54% | -$410K |
|
79
Unilever
UL
$156B
| $353K | 0.23% |
6,230
+35
| +0.6% | +$1.99K |
|
80
Novartis
NVS
$245B
| $353K | 0.23% |
3,627
-60
| -2% | -$5.84K |
|
81
Equinix
EQIX
$75.7B
| $349K | 0.23% |
370
-25
| -6% | -$23.6K |
|
82
CACI
CACI
$10.5B
| $341K | 0.22% |
845
-40
| -5% | -$16.2K |
|
83
ASML
ASML
$283B
| $341K | 0.22% |
492
+10
| +2% | +$6.93K |
|
84
Casella Waste Systems
CWST
$6.21B
| $334K | 0.22% |
3,160
-25
| -0.8% | -$2.65K |
|
85
Target
TGT
$42.4B
| $332K | 0.22% |
2,453
| – | – |
|
86
Simon Property Group
SPG
$58.4B
| $323K | 0.21% |
1,875
-175
| -9% | -$30.1K |
|
87
Invesco QQQ Trust
QQQ
$360B
| $321K | 0.21% |
627
| – | – |
|
88
ING
ING
$70.2B
| $318K | 0.21% |
20,305
-350
| -2% | -$5.48K |
|
89
Regions Financial
RF
$23.9B
| $313K | 0.2% |
13,296
| – | – |
|
90
Performance Food Group
PFGC
$16.3B
| $307K | 0.2% |
3,626
-75
| -2% | -$6.34K |
|
91
Neurocrine Biosciences
NBIX
$14B
| $299K | 0.19% |
2,190
| – | – |
|
92
PepsiCo
PEP
$209B
| $298K | 0.19% |
1,962
| – | – |
|
93
AstraZeneca
AZN
$249B
| $298K | 0.19% |
4,545
+370
| +9% | +$24.2K |
|
94
Exxon Mobil
XOM
$487B
| $295K | 0.19% |
2,745
-75
| -3% | -$8.07K |
|
95
TD Synnex
SNX
$12.1B
| $291K | 0.19% |
2,485
-25
| -1% | -$2.93K |
|
96
VICI Properties
VICI
$35.8B
| $289K | 0.19% |
9,894
-275
| -3% | -$8.03K |
|
97
Prologis
PLD
$103B
| $289K | 0.19% |
2,732
+81
| +3% | +$8.56K |
|
98
Addus HomeCare
ADUS
$2.14B
| $286K | 0.19% |
2,280
+40
| +2% | +$5.01K |
|
99
Ligand Pharmaceuticals
LGND
$3.17B
| $284K | 0.18% |
2,655
+75
| +3% | +$8.04K |
|
100
Sanofi
SNY
$120B
| $284K | 0.18% |
5,890
+150
| +3% | +$7.24K |
|